{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:17:38Z","timestamp":1789759058066,"version":"4.0.1"},"reference-count":37,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2015,9,5]]},"abstract":"<jats:p>In most settings, approved medications for the treatment of opioid-use disorder include methadone and buprenorphine\/naloxone, and in some settings, naltrexone. We present a case in which methadone administration was associated with an in-hospital episode of Torsades de Pointes in a patient who was subsequently maintained on sustained release oral morphine (SROM) for treatment of his opioid-use disorder. This transition was made in the context of long-term compliance to methadone maintenance, and with a previous adverse reaction to buprenorphine\/naloxone precluding its use. The change to SROM, supported by emerging evidence, resulted in a reduction in the patient's measured QTc interval, prevention of further arrhythmias and continued abstinence from illicit opioid-use. In this context, we believe careful consideration should be given to the use of SROM.<\/jats:p>","DOI":"10.1136\/bcr-2015-210239","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T04:07:41Z","timestamp":1442808461000},"page":"bcr2015210239","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrest"],"prefix":"10.1136","volume":"2015","author":[{"given":"Geoffrey","family":"Walton","sequence":"first","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonaid","family":"Nolan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Urban Health Research Initiative, BC Centre for Excellence in HIV\/AIDS, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Ahamad","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Urban Health Research Initiative, BC Centre for Excellence in HIV\/AIDS, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cki168"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg022"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.3","doi-asserted-by":"crossref","unstructured":"Minozzi S , Amato L , Vecchi S , et al . Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2011 (4):Cd001333. doi:10.1002\/14651858.CD001333.pub4","DOI":"10.1002\/14651858.CD001333.pub3"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.05.021"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01089.x"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.6","doi-asserted-by":"crossref","unstructured":"Mattick RP , Breen C , Kimber J , et al . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;(3):Cd002209. doi:10.1002\/14651858.CD002209.pub2","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.7","doi-asserted-by":"crossref","unstructured":"Gowing L , Farrell MF , Bornemann R , et al . Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2011;(8):Cd004145. doi:10.1002\/14651858.CD004145.pub4","DOI":"10.1002\/14651858.CD004145.pub4"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02866.x"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.12.1280"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-6-200209170-00010"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.11","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.4.611.61020"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.12","doi-asserted-by":"crossref","unstructured":"Mattick RP , Breen C , Kimber J , et al . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;(2):Cd002207. doi:10.1002\/14651858.CD002207.pub4","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03108.x"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.14","unstructured":"Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004."},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.15","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000059"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2007.03.053"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.07.068"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.05.012"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.20","doi-asserted-by":"publisher","DOI":"10.1111\/add.12440"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.21","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.093393"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.22","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.802.32186"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.23","doi-asserted-by":"publisher","DOI":"10.1159\/000167043"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.10.009"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.25","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.120295"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.26","doi-asserted-by":"crossref","first-page":"w13852","DOI":"10.4414\/smw.2013.13852","article-title":"QTc prolongation in methadone maintenance--the role of HCV infection","volume":"143","author":"Gholami","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022147"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510210076031"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00103"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.30","doi-asserted-by":"crossref","unstructured":"Pani PP , Trogu E , Maremmani I , et al . QTc interval screening for cardiac risk in methadone treatment of opioid dependence. Cochrane Database Syst Rev 2013;(6):Cd008939. doi:10.1002\/14651858.CD008939.pub2","DOI":"10.1002\/14651858.CD008939.pub2"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/02024458-201406000-00003","article-title":"Variability of QT interval measurements in opioid-dependent patients on methadone","volume":"5","author":"Worster","year":"2014","journal-title":"Can J Addict"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2004.09.001"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/02024458-201406000-00004","article-title":"Methadone and QTc screening: Weighing the risks and benefits","volume":"5","author":"Nolan","year":"2014","journal-title":"Can J Addict"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-008-9280-8"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810635"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.36","doi-asserted-by":"crossref","unstructured":"Ferri M , Minozzi S , Bo A , et al . Slow-release oral morphine as maintenance therapy for opioid dependence. Cochrane Database Syst Rev 2013;(6):Cd009879. doi:10.1002\/14651858.CD009879.pub2","DOI":"10.1002\/14651858.CD009879.pub2"},{"key":"2025082800385072000_2015.sep21_1.bcr2015210239.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.194.6.646"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2015-210239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:39:02Z","timestamp":1756366742000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2015-210239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":37,"alternative-id":["10.1136\/bcr-2015-210239"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2015-210239","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]}}}